Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:30PM EST. Market open.
| Previous close | 74.45 |
| Open | 74.45 |
| Bid | 74.46 x 900 |
| Ask | 74.48 x 800 |
| Day's range | 74.39 - 75.18 |
| 52-week range | 65.00 - 81.44 |
| Volume | |
| Avg. volume | 9,026,745 |
| Market cap | 158.165B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 25.22 |
| EPS (TTM) | 2.95 |
| Earnings date | 27 Apr 2023 |
| Forward dividend & yield | 2.28 (3.06%) |
| Ex-dividend date | 05 Jan 2023 |
| 1y target est | 82.49 |
- Motley Fool
Could This Indication Provide a Lift for Bristol Myers Squibb's Stock?
Bristol Myers' Sotyktu recently moved one step closer to its first approval in the European Union.
- Motley Fool
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Shares in pharmaceutical company Bristol Myers Squibb (NYSE: BMY) are up a little more than 11% over the past year. The company posted third-quarter revenue of $11.2 billion, a decrease of 3%, with one culprit being the loss of exclusivity for one of its blockbuster drugs, Revlimid. The blood cancer therapy reported sales of $2.4 billion, down 28% year over year.
- Simply Wall St.
Bristol-Myers Squibb Full Year 2022 Earnings: In Line With Expectations
Bristol-Myers Squibb ( NYSE:BMY ) Full Year 2022 Results Key Financial Results Revenue: US$46.2b (flat on FY 2021). Net...
© 2023 Yahoo. All rights reserved.
